πŸ‡ΊπŸ‡Έ FDA
Patent

US 9901546

Orally disintegrable tablets

granted A61KA61K31/4439A61K9/0056

Quick answer

US patent 9901546 (Orally disintegrable tablets) held by Takeda Pharmaceutical Company Limited expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/4439, A61K9/0056, A61K9/1611, A61K9/1652